Statera BioPharma (STU:7CB) Scaled Net Operating Assets : -0.26 (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Statera BioPharma's operating assets for the quarter that ended in Sep. 2022 was €12.37 Mil. Statera BioPharma's operating liabilities for the quarter that ended in Sep. 2022 was €15.67 Mil. Statera BioPharma's Total Assets for the quarter that ended in Jun. 2022 was €12.81 Mil. Therefore, Statera BioPharma's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2022 was -0.26.

Statera BioPharma Scaled Net Operating Assets Historical Data

The historical data trend for Statera BioPharma's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Scaled Net Operating Assets Chart

Statera BioPharma Annual Data

Trend

Dec19

Dec20

Dec21

Scaled Net Operating Assets

-1,083.00

-923.00

13.29

Statera BioPharma Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Scaled Net Operating Assets	Get a 7-Day Free Trial						-	0.14	0.21	-0.01	-0.26

Competitive Comparison of Statera BioPharma's Scaled Net Operating Assets

For the Biotechnology subindustry, Statera BioPharma's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Statera BioPharma's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Statera BioPharma's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Statera BioPharma's Scaled Net Operating Assets falls into.

Statera BioPharma Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Statera BioPharma's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2021 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2021 )
=	(Operating Assets (A: Dec. 2021 )	-	Operating Liabilities (A: Dec. 2021 ))	/	Total Assets (A: Dec. 2020 )
=	(16.984	-	5.677)	/	0.851
=	13.29

where

	Operating Assets		(A: Dec. 2021 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	18.735	-	1.751
=	16.984

	Operating Liabilities		(A: Dec. 2021 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	20.068	-	10.116	-	4.275
=	5.677

Statera BioPharma's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2022 )
=	(Operating Assets (Q: Sep. 2022 )	-	Operating Liabilities (Q: Sep. 2022 ))	/	Total Assets (Q: Jun. 2022 )
=	(12.365	-	15.666)	/	12.811
=	-0.26

where

	Operating Assets		(Q: Sep. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	12.876	-	0.511
=	12.365

	Operating Liabilities		(Q: Sep. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	23.146	-	0.693	-	6.787
=	15.666

Statera BioPharma Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Statera BioPharma's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Statera BioPharma (STU:7CB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525

Website

https://www.staterabiopharma.com

Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma (STU:7CB) Headlines

No Headlines